SCHEMBL29975689

SCHEMBL29975689

COc1ccc(Cc2c(C(F)(F)F)cnc(N)c2Cc2ccc(OC)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
CYP2D6 P10635 1/20 0.52
ATM Q13315 1/20 0.52
POLB P06746 1/20 0.46
PIK3CA P42336 1/20 0.46
LMNA P02545 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NPSR1 Q6W5P4 1/20 0.43
HPGD P15428 1/20 0.40
LTA4H P09960 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
PTK2 Q05397 1/20 0.39
IDO1 P14902 1/20 0.38
NR1H2 P55055 1/20 0.38
NR1H3 Q13133 1/20 0.38
MBOAT4 Q96T53 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28515732 0.89 ALDH1A1 (0.50) ALDH1A1CYP2D6ATMPOLBPIK3CA
SCHEMBL16668538 0.82 ALDH1A1 (0.43) ALDH1A1CYP2D6ATMPOLBPIK3CA
SCHEMBL28996034 0.78 ALDH1A1 (0.56) ALDH1A1CYP2D6ATMPOLBLMNA
SCHEMBL29687392 0.78 ALDH1A1 (0.56) ALDH1A1CYP2D6ATMPOLBLMNA
SCHEMBL29433996 0.77 ALDH1A1 (0.58) ALDH1A1CYP2D6ATMPOLBLMNA
SCHEMBL28729752 0.77 ALDH1A1 (0.58) ALDH1A1CYP2D6ATMPOLBLMNA
SCHEMBL30998660 0.76 ALDH1A1 (0.48) ALDH1A1CYP2D6ATMPOLBLMNA
Ammonia Solution, Strong SCHEMBL26694782 0.76 ALDH1A1 (0.43) ALDH1A1CYP2D6ATMPOLBPIK3CA
SCHEMBL29937376 0.75 ALDH1A1 (0.56) ALDH1A1CYP2D6ATMPOLBLMNA
Hydrochloric Acid SCHEMBL7522555 0.74 ALDH1A1 (0.68) ALDH1A1CYP2D6ATMPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4329757-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2024-03-06 EP disclosed
WO-2022232331-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2022-11-03 WO disclosed